Ignite Creation Date:
2025-12-26 @ 10:34 AM
Ignite Modification Date:
2026-03-14 @ 8:40 PM
Study NCT ID:
NCT02889328
Status:
COMPLETED
Last Update Posted:
2020-01-09
First Post:
2016-08-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of Regorafenib Continuous Dosing of Regorafenib in Patients With GISTs
Sponsor:
Asan Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09
Start Date Type:
None
Primary Completion Date:
2017-08-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-31
First Submit QC Date:
None
Study First Post Date:
2016-09-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-01-06
Last Update Post Date:
2020-01-09
Last Update Post Date Type:
ACTUAL